Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Lamyae Nouiakh"'
Autor:
Imane Ouafki, Lamyae Nouiakh, Raihana Boujarnija, Afaf Amarti, Lamiae Amaadour, Karima Oualla, Zineb Benbrahim, Samia Arifi, Nawfel Mellas
Publikováno v:
The Pan African Medical Journal, Vol 38, Iss 92 (2021)
Le mésothéliome malin primitif de l´ovaire (MMPO) est une tumeur extrêmement rare qui peut se développer à partir des cellules mésothéliales. Cette néoplasie est causée principalement par une exposition à l´amiante ou à d´autres agents
Externí odkaz:
https://doaj.org/article/7ef15ae2cb4f40a1a900683d7f2e331d
Autor:
Soumia Berrad, Hayat Erraichi, Zineb Benbrahim, Lamyae Nouiakh, Lamiae Amaadour, Samira El Fakir, Mariam Atassi, Nawfel Mellas, Samia Arifi, Imane Ouafki, Karima Oualla
Publikováno v:
Advances in Lung Cancer. 10:1-10
Introduction: Non-small cell lung cancer is the most common lung cancer. Despite the therapeutic advances, its prognosis is very reserved. Aim: Determine the different prognostic factors of patients with metastatic non-small cell lung cancer and thei
Autor:
Nawfel Mellas, Soumia Berrad, Lamyae Nouiakh, Zineb Benbrahim, Karima Oualla, Samia Arifi, Imane Ouafki, Hayat Erraichi, Lamiae Amaadour
Publikováno v:
Open Journal of Nephrology. 11:34-42
Background: Non-clear cell renal cell carcinomas represent a very rare and heterogeneous variety of kidney cancer. The aim of this study is to describe the main epidemiological, clinical, paraclinical, histological and therapeutic characteristics of
Autor:
Lamiae Amaadour, Zineb Benbrahim, Imane Ouafki, Hayat Erraichi, Karima Oualla, Samia Arifi, Soumia Berrad, Lamyae Nouiakh, Nawfel Mellas
Publikováno v:
Journal of Cancer Therapy. 12:116-126
Tyrosine kinase inhibitors (TKIs) have become a prominent option in the therapeutic arsenal of several cancers. The safety of these drugs has shown various toxicities with varying frequency and severity between different agents. The aim of this study
Autor:
Hind El Fatemi, Nawfel Mellas, Meryem Boubou, Zineb Benbrahim, Soumia Berrad, Lamyae Nouiakh, Karima Oualla, Imane Ouafki, Younes Dkhissi, Samia Arifi, Hayat Erraichi, Lamiae Amaadour
Publikováno v:
Journal of Cancer Prevention & Current Research. 11:148-152
Autor:
Soumia Berrad, Hayat Erraichi, Samia Arifi, Meryem Boubou, Karima Oualla, Nawfel Mellas, Lamiae Amaadour, Hajar Ouahbi, Zineb Benbrahim, Lamyae Nouiakh
Publikováno v:
International Journal of Innovative Research in Medical Science. 5:606-610
Background: Refractory thyroid carcinomas are rare. The prognosis of these carcinomas depends on several factors including the histological type and the evolutionary stage. Aim: Determine the epidemiological, pathological and prognostic characteristi
Autor:
Lamyae Nouiakh
Publikováno v:
American Journal of Biomedical Science & Research. 11:138-141
Autor:
Lamyae Nouiakh
Publikováno v:
American Journal of Biomedical Science & Research. 10:523-526
Autor:
Raihana Boujarnija, Imane Ouafki, Lamyae Nouiakh, Afaf Amarti, Zineb Benbrahim, Nawfel Mellas, Samia Arifi, Lamiae Amaadour, Karima Oualla
Publikováno v:
Pan African Medical Journal; Vol. 38 No. 1 (2021)
The Pan African Medical Journal
The Pan African Medical Journal
Le mésothéliome malin primitif de l´ovaire (MMPO) est une tumeur extrêmement rare qui peut se développer à partir des cellules mésothéliales. Cette néoplasie est causée principalement par une exposition à l´amiante ou à d´autres agents
Autor:
Samia Arifi, Karima Oualla, Soufiane Mellas, meriam benhami, Hinde Elfatemi, Fadl Tazi, Nawfel Mellas, Lamiae Amaadour, Lamyae Nouiakh, Moulay Hassan Farih, Zineb Benbrahim, Khaoula El Kinany, Samira El Fakir
Background: Available treatments for metastatic RCC (mRCC) are usually non-curative. In the last decade, novel targeted therapies have significantly improved mRCC outcome. The objective in this study was to describe outcomes in patients with mRCC in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b5e03f5b53ddbc4f976ae02d0d6eb7e
https://doi.org/10.21203/rs.3.rs-150282/v1
https://doi.org/10.21203/rs.3.rs-150282/v1